AgingResearch.News
Archives of Osteoporosis

Keeping bone resorption markers very low for 1 year after denosumab prevents bone loss at 2 years: the ReoLaus study

By Giovanni Liebich, Olivier Lamy, Jérôme Pasquier, Elena González Rodríguez
Cohort study of 161 peopleBiomarkers

2 years

Paper

The paper

Giovanni Liebich, Olivier Lamy, Jérôme Pasquier, Elena González Rodríguez

University of Lausanne; Centre Hospitalier Universitaire Vaudois

Archives of Osteoporosis, 8 Aug 2026

doi.org/10.1007/s11657-026-01747-0PubMed 42570164

Related